Selected research
Industry Research
Tumor Registry Software Industry Research Report 2026
Market perspective
The global Tumor Registry Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Tumor Registry Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Tumor Registry Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Tumor Registry Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Tumor Registry Software include C/NET Solutions, Conduent Inc., Electronic Registry System Inc., Elekta, Himagine solutions, IBM Corporation, McKesson Corporation, NeuralFrame,Inc. and Onco Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Tumor Registry Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Tumor Registry Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tumor Registry Software Market by Company
C/NET Solutions
Conduent Inc.
Electronic Registry System Inc.
Elekta
Himagine solutions
IBM Corporation
McKesson Corporation
NeuralFrame,Inc.
Onco Inc.
Ordinal Data Inc.
Rocky Mountain Cancer Data Systems
Tumor Registry Software Segment by Type
On Premise
Cloud Based
Tumor Registry Software Segment by Application
Government and Third Party
Hospital and Medical Practice
Others
Tumor Registry Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Registry Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Registry Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Registry Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Tumor Registry Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On Premise
- Cloud Based
Applications
- Government and Third Party
- Hospital and Medical Practice
- Others
Companies covered
- C/NET Solutions
- Conduent Inc.
- Electronic Registry System Inc.
- Elekta
- Himagine solutions
- IBM Corporation
- McKesson Corporation
- NeuralFrame,Inc.
- Onco Inc.
- Ordinal Data Inc.
- Rocky Mountain Cancer Data Systems
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Tumor Registry Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 On Premise
- 2.2.3 Cloud Based
- 2.3 Tumor Registry Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Government and Third Party
- 2.3.3 Hospital and Medical Practice
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Tumor Registry Software Breakdown Data by Type
- 3.1 Global Tumor Registry Software Historic Market Size by Type (2021-2026)
- 3.2 Global Tumor Registry Software Forecasted Market Size by Type (2027-2032)
4 Tumor Registry Software Breakdown Data by Application
- 4.1 Global Tumor Registry Software Historic Market Size by Application (2021-2026)
- 4.2 Global Tumor Registry Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Tumor Registry Software Market Perspective (2021-2032)
- 5.2 Global Tumor Registry Software Growth Trends by Region
- 5.2.1 Global Tumor Registry Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Tumor Registry Software Historic Market Size by Region (2021-2026)
- 5.2.3 Tumor Registry Software Forecasted Market Size by Region (2027-2032)
- 5.3 Tumor Registry Software Market Dynamics
- 5.3.1 Tumor Registry Software Industry Trends
- 5.3.2 Tumor Registry Software Market Drivers
- 5.3.3 Tumor Registry Software Market Challenges
- 5.3.4 Tumor Registry Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Tumor Registry Software Players by Revenue
- 6.1.1 Global Top Tumor Registry Software Players by Revenue (2021-2026)
- 6.1.2 Global Tumor Registry Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Tumor Registry Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Tumor Registry Software Head Office and Area Served
- 6.4 Global Tumor Registry Software Players, Product Type & Application
- 6.5 Global Tumor Registry Software Manufacturers Established Date
- 6.6 Global Tumor Registry Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Tumor Registry Software Market Size (2021-2032)
- 7.2 North America Tumor Registry Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Tumor Registry Software Market Size by Country (2021-2026)
- 7.4 North America Tumor Registry Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Tumor Registry Software Market Size (2021-2032)
- 8.2 Europe Tumor Registry Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Tumor Registry Software Market Size by Country (2021-2026)
- 8.4 Europe Tumor Registry Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Tumor Registry Software Market Size (2021-2032)
- 9.2 Asia-Pacific Tumor Registry Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Tumor Registry Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Tumor Registry Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Tumor Registry Software Market Size (2021-2032)
- 10.2 South America Tumor Registry Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Tumor Registry Software Market Size by Country (2021-2026)
- 10.4 South America Tumor Registry Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Tumor Registry Software Market Size (2021-2032)
- 11.2 Middle East & Africa Tumor Registry Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Tumor Registry Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Tumor Registry Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 C/NET Solutions
- 12.1.1 C/NET Solutions Company Information
- 12.1.2 C/NET Solutions Business Overview
- 12.1.3 C/NET Solutions Revenue in Tumor Registry Software Business (2021-2026)
- 12.1.4 C/NET Solutions Tumor Registry Software Product Portfolio
- 12.1.5 C/NET Solutions Recent Developments
- 12.2 Conduent Inc.
- 12.2.1 Conduent Inc. Company Information
- 12.2.2 Conduent Inc. Business Overview
- 12.2.3 Conduent Inc. Revenue in Tumor Registry Software Business (2021-2026)
- 12.2.4 Conduent Inc. Tumor Registry Software Product Portfolio
- 12.2.5 Conduent Inc. Recent Developments
- 12.3 Electronic Registry System Inc.
- 12.3.1 Electronic Registry System Inc. Company Information
- 12.3.2 Electronic Registry System Inc. Business Overview
- 12.3.3 Electronic Registry System Inc. Revenue in Tumor Registry Software Business (2021-2026)
- 12.3.4 Electronic Registry System Inc. Tumor Registry Software Product Portfolio
- 12.3.5 Electronic Registry System Inc. Recent Developments
- 12.4 Elekta
- 12.4.1 Elekta Company Information
- 12.4.2 Elekta Business Overview
- 12.4.3 Elekta Revenue in Tumor Registry Software Business (2021-2026)
- 12.4.4 Elekta Tumor Registry Software Product Portfolio
- 12.4.5 Elekta Recent Developments
- 12.5 Himagine solutions
- 12.5.1 Himagine solutions Company Information
- 12.5.2 Himagine solutions Business Overview
- 12.5.3 Himagine solutions Revenue in Tumor Registry Software Business (2021-2026)
- 12.5.4 Himagine solutions Tumor Registry Software Product Portfolio
- 12.5.5 Himagine solutions Recent Developments
- 12.6 IBM Corporation
- 12.6.1 IBM Corporation Company Information
- 12.6.2 IBM Corporation Business Overview
- 12.6.3 IBM Corporation Revenue in Tumor Registry Software Business (2021-2026)
- 12.6.4 IBM Corporation Tumor Registry Software Product Portfolio
- 12.6.5 IBM Corporation Recent Developments
- 12.7 McKesson Corporation
- 12.7.1 McKesson Corporation Company Information
- 12.7.2 McKesson Corporation Business Overview
- 12.7.3 McKesson Corporation Revenue in Tumor Registry Software Business (2021-2026)
- 12.7.4 McKesson Corporation Tumor Registry Software Product Portfolio
- 12.7.5 McKesson Corporation Recent Developments
- 12.8 NeuralFrame,Inc.
- 12.8.1 NeuralFrame,Inc. Company Information
- 12.8.2 NeuralFrame,Inc. Business Overview
- 12.8.3 NeuralFrame,Inc. Revenue in Tumor Registry Software Business (2021-2026)
- 12.8.4 NeuralFrame,Inc. Tumor Registry Software Product Portfolio
- 12.8.5 NeuralFrame,Inc. Recent Developments
- 12.9 Onco Inc.
- 12.9.1 Onco Inc. Company Information
- 12.9.2 Onco Inc. Business Overview
- 12.9.3 Onco Inc. Revenue in Tumor Registry Software Business (2021-2026)
- 12.9.4 Onco Inc. Tumor Registry Software Product Portfolio
- 12.9.5 Onco Inc. Recent Developments
- 12.10 Ordinal Data Inc.
- 12.10.1 Ordinal Data Inc. Company Information
- 12.10.2 Ordinal Data Inc. Business Overview
- 12.10.3 Ordinal Data Inc. Revenue in Tumor Registry Software Business (2021-2026)
- 12.10.4 Ordinal Data Inc. Tumor Registry Software Product Portfolio
- 12.10.5 Ordinal Data Inc. Recent Developments
- 12.11 Rocky Mountain Cancer Data Systems
- 12.11.1 Rocky Mountain Cancer Data Systems Company Information
- 12.11.2 Rocky Mountain Cancer Data Systems Business Overview
- 12.11.3 Rocky Mountain Cancer Data Systems Revenue in Tumor Registry Software Business (2021-2026)
- 12.11.4 Rocky Mountain Cancer Data Systems Tumor Registry Software Product Portfolio
- 12.11.5 Rocky Mountain Cancer Data Systems Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst